The mission of the Microtechnology Core (MTC) is to provide access to enabling micro scale technologies. Specifically, the MTC will work with researchers to develop and apply advanced
microscale cell-based assays to enhance basic cell biology research and enable clinical studies. An important goal of the MTC is to incorporate cutting edge technologies into funding proposals to act as a differentiator in a competitive funding environment.
Examples of enabling capabilities include:
- Increased sensitivity to paracrine signaling
- Discrete compartmentalization and analysis of different cell types
- Enable studies with small (e.g. patient samples) samples and rare cell populations
- Enable multi-analyte, multi-omic endpoints from a single sample/aliquot
- Organotypic models (e.g. vascular, ductal)
- Enhanced control of microenvironment parameters (e.g. matrix composition, matrix alignment, relative spatial organization, soluble factor concentration/gradient)
Any published research which received funding from the UWCCC Cancer Center Support Grant (CCSG), including the use of UWCCC Shared Resources to generate or analyze data or conduct clinical trials, must reference the UWCCC. See Acknowledging UWCCC in Publications, Posters and Presentations.